Good to Globe, the mission of G2GBIO, is meant to supply good medicines to patients all over the world and practice "Respect for Life"
G2GBIO is devoted to developing improved long acting medicines by enhancing the convenience of medication and adherence of medication to patients with chronic diseases such as dementia.
G2GBIO has many experienced employees who have engaged in developing new sustained drug delivery systems.
G2GBIO possesses cutting edge proprietary "InnoLAMP" technology which can be harnessed to develop improved controlled-release drug products.
We plan to expand our business areas in near future by exploring potential usages of the "InnoLAMP" technology to improve the efficacy of other drugs for chronic diseases such as diabetes and cancers.
We are doing our best with the mindset of "Challenge", "Cooperation" and "Creativity" to become a world-class biotechnology company.